BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 23024024)

  • 1. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
    Mallia P; Footitt J; Sotero R; Jepson A; Contoli M; Trujillo-Torralbo MB; Kebadze T; Aniscenko J; Oleszkiewicz G; Gray K; Message SD; Ito K; Barnes PJ; Adcock IM; Papi A; Stanciu LA; Elkin SL; Kon OM; Johnson M; Johnston SL
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1117-24. PubMed ID: 23024024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
    Molyneaux PL; Mallia P; Cox MJ; Footitt J; Willis-Owen SA; Homola D; Trujillo-Torralbo MB; Elkin S; Kon OM; Cookson WO; Moffatt MF; Johnston SL
    Am J Respir Crit Care Med; 2013 Nov; 188(10):1224-31. PubMed ID: 23992479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
    Zhu J; Mallia P; Footitt J; Qiu Y; Message SD; Kebadze T; Aniscenko J; Barnes PJ; Adcock IM; Kon OM; Johnson M; Contoli M; Stanciu LA; Papi A; Jeffery PK; Johnston SL
    J Allergy Clin Immunol; 2020 Oct; 146(4):840-850.e7. PubMed ID: 32283204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.
    Mallia P; Message SD; Gielen V; Contoli M; Gray K; Kebadze T; Aniscenko J; Laza-Stanca V; Edwards MR; Slater L; Papi A; Stanciu LA; Kon OM; Johnson M; Johnston SL
    Am J Respir Crit Care Med; 2011 Mar; 183(6):734-42. PubMed ID: 20889904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Tsoumakidou M; Bouloukaki I; Thimaki K; Tzanakis N; Siafakas NM
    Exp Lung Res; 2010 Aug; 36(6):373-80. PubMed ID: 20653472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.
    Footitt J; Mallia P; Durham AL; Ho WE; Trujillo-Torralbo MB; Telcian AG; Del Rosario A; Chang C; Peh HY; Kebadze T; Aniscenko J; Stanciu L; Essilfie-Quaye S; Ito K; Barnes PJ; Elkin SL; Kon OM; Wong WS; Adcock IM; Johnston SL
    Chest; 2016 Jan; 149(1):62-73. PubMed ID: 25790167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations.
    Rohde G; Message SD; Haas JJ; Kebadze T; Parker H; Laza-Stanca V; Khaitov MR; Kon OM; Stanciu LA; Mallia P; Edwards MR; Johnston SL
    Clin Exp Allergy; 2014 Jul; 44(7):930-9. PubMed ID: 24673807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Peptides SLPI and Beta Defensin-1 in Sputum are Negatively Correlated with FEV
    Cane J; Tregidgo L; Thulborn S; Finch D; Bafadhel M
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1437-1447. PubMed ID: 34093009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human rhinovirus infection during naturally occurring COPD exacerbations.
    George SN; Garcha DS; Mackay AJ; Patel AR; Singh R; Sapsford RJ; Donaldson GC; Wedzicha JA
    Eur Respir J; 2014 Jul; 44(1):87-96. PubMed ID: 24627537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral immunity is impaired in COPD patients with frequent exacerbations.
    Singanayagam A; Loo SL; Calderazzo M; Finney LJ; Trujillo Torralbo MB; Bakhsoliani E; Girkin J; Veerati P; Pathinayake PS; Nichol KS; Reid A; Footitt J; Wark PAB; Grainge CL; Johnston SL; Bartlett NW; Mallia P
    Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L893-L903. PubMed ID: 31513433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chance favors the prepared mind.
    Sethi S
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1070-1. PubMed ID: 23204370
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD.
    Parameswaran GI; Sethi S; Murphy TF
    Chest; 2011 Sep; 140(3):611-617. PubMed ID: 21349930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral E1A suppresses secretory leukoprotease inhibitor and elafin secretion in human alveolar epithelial cells and bronchial epithelial cells.
    Higashimoto Y; Yamagata Y; Iwata T; Ishiguchi T; Okada M; Masuda M; Satoh H; Itoh H
    Respiration; 2005; 72(6):629-35. PubMed ID: 16355004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.
    Persson LJ; Aanerud M; Hardie JA; Miodini Nilsen R; Bakke PS; Eagan TM; Hiemstra PS
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28298400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum and nasal lavage lung-specific biomarkers before and after smoking cessation.
    Bouloukaki I; Tsiligianni IG; Tsoumakidou M; Mitrouska I; Prokopakis EP; Mavroudi I; Siafakas NM; Tzanakis N
    BMC Pulm Med; 2011 Jun; 11():35. PubMed ID: 21635782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
    Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
    Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
    Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.
    Quint JK; Donaldson GC; Goldring JJ; Baghai-Ravary R; Hurst JR; Wedzicha JA
    Chest; 2010 Apr; 137(4):812-22. PubMed ID: 19837822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease.
    Parameswaran GI; Wrona CT; Murphy TF; Sethi S
    BMC Infect Dis; 2009 Nov; 9():178. PubMed ID: 19912665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
    Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.